PETS
Petmed Express
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 2
consensus rating "Sell"
Net Income Surges
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About PETS
Petmed Express, Inc.
A leading pet pharmacy in the US
Consumer Goods Distribution and Retail
Invalid Date
01/23/2004
NASDAQ Stock Exchange
287
03-31
Common stock
420 South Congress Avenue, Delray Beach, Florida 33445
--
Founded in January 1996 in Florida, Petmed Express, Inc., and its affiliates sell prescription and over-the-counter medicines for pets, as well as other dog and cat health supplements, in the form of direct sales to consumers. The company allows consumers to easily buy pet medicines, and has advantages in price and delivery speed. The company offers a wide selection of products for dogs and cats. The company's current product line contains approximately 1,200 SKUs. These products include most well-known brand drugs, and in general, the company's products are cheaper than the prices charged by veterinarians and retailers. PetMed Express was founded in Florida in January 1996.
Company Financials
EPS
PETS has released its 2025 Q3 earnings. EPS was reported at -0.03, versus the expected -0.01, missing expectations. The chart below visualizes how PETS has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PETS has released its 2025 Q3 earnings report, with revenue of 52.98M, reflecting a YoY change of -18.88%, and net profit of -707.00K, showing a YoY change of 65.12%. The Sankey diagram below clearly presents PETS’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
